Logo - springer
Slogan - springer

Life Sciences - Biochemistry & Biophysics | Metabolomics - incl. option to publish open access (Editorial Board)

We’re working on a new version of this journal site - preview it now


Editor-in-Chief: Royston Goodacre

ISSN: 1573-3882 (print version)
ISSN: 1573-3890 (electronic version)

Journal no. 11306

76,25 € Personal Rate e-only
Get Subscription

Online subscription, valid from January through December of current calendar year

Immediate access to this year's issues via SpringerLink

1 Volume(-s) with 12 issue(-s) per annual subscription

Automatic annual renewal

More information: >> FAQs // >> Policy

Royston Goodacre, Institute of Integrative Biology, University of Liverpool, UK

Reviews Editor: 
Warwick Dunn, School of Biosciences at University of Birmingham, UK

Editorial Advisory Board: 

William Allwood, Environmental & Biochemical Sciences Group, The James Hutton Institute, Scotland, UK
Richard D. Beger, Division of Systems Toxicology, National Center for Toxicological Research, Food and Drug Administration, USA
Laszlo Boros, UCLA School of Medicine and Division of Pediatric Endocrinology, Co-Director, Stable Isotope Research Laboratory, Harbor-UCLA Medical Center, Torrance, CA, USA
Fernando Carrari, Instituto de Fisiología, Biología Molecular y Neurociencias, Buenos Aires, Argentina
Marta Cascante, University of Barcelona, Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain
Teresa W.M. Fan, Graduate Department of Toxicology and Markey Cancer Center, University of Kentucky, Lexington, KY, USA
Oliver Fiehn, University of California, Davis, CA, USA
Eiichiro Fukusaki, Department of Biotechnology, Graduate School of engineering, Osaka Univrsity, Osaka, Japan
Robert Hall, Plant Research International, Wageningen, The Netherlands
George G. Harrigan, Monsanto, St. Louis, MO, USA
John Haselden, Metabolic Profiling Group, GlaxoSmithKline,Ware, Hertfordshire, UK
Tuulia Hyötyläinen, School of science and Technology, Örebro University, Örebro, Sweden
Julijana Ivanisevic, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland
Jeroen Jansen, Department of Analytical Chemistry and Chemometrics, Institute for Molecules and Materials, Radboud University Nijmegen, Nijmegen, The Netherlands
Caroline Johnson, Department of Environmental Health Sciences, Yale School of Public Health, New Haven, CT, USA
Rima Kaddurah-Daouk, Duke University Medical Center and Co-founder Metabolon, Durham, NC, USA
Jennifer Kirwan, Berlin Institute of Health/Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany 
Andrew Lane, Graduate Department of Toxicology and Markey Cancer Center, University of Kentucky, Lexington, KY, USA
Paul Lee, UCLA School of Medicine and Division of Pediatric Endocrinology, Stable Isotope Research Laboratory, Harbor-UCLA Medical Center, Torrance, CA, USA
Jang R. Liu, Korean Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Korea
Amanda Lloyd, Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Aberystwyth, Wales, UK
Annick Moing, Fruit Biology and Pathology, Centre INRA de Bordeaux, Villenave d’Ornon, France
Matej Oresic, Turku Centre For Biotechnology, University of Turku, Turku, Finland
Sastia Prama Putri, Graduate School of Engineering, Osaka University, Osaka, Japan
Stacey Reinke, School of Science, Edith Cowan University, Joondalup, WA, Australia
Simone Rochfort, School of Applied Systems Biology, LaTrobe University, Victoria, Australia
Ute Roessner, Australian Centre for Plant Functional Genomics and Metabolomics Australia, The University of Melbourne, School of Botany, Australia
Raja Roy, Centre of Biomedical Research, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Uttar Pradesh, India
Jan Schripsema, Universidade Estadual do Norte Fluminense, Grupo Metabolômica, Campos dos Goytacazes, Brazil
Laura Schneckenberg, Division of Systems Biology, National Center for Toxicological Research, Jefferson, AR, USA
Lloyd W. Sumner, University of Missouri, MU Metabolomics Center, Columbia, MO, USA
Susan Sumner, RTI International, Research Triangle Park, NC, USA
Huiru Tang, Fudan University, School of Life Science, Shanghai, China
Stefano Tiziani, Department of Nutritional Science, The University of Texas at Austin, Austin, TX, USA
Mark Viant, School of Biosciences, University of Birmingham, UK
Yulan Wang, University of Chinese Academy of Sciences, Wuhan, China
Steve Watkins, President Lipomics Technologies, Inc., West Sacramento, CA, USA
Johan Westerhuis, Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, The Netherlands
Guowang Xu, National Chromatographic R. & A. Center, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China

For authors and editors

  • Journal Citation Reports®
    2018 Impact Factor
  • 3.167
  • Aims and Scope

    Aims and Scope


    Metabolomics publishes current research regarding the development of technology platforms for metabolomics. This includes, but is not limited to:

    •  metabolomic applications within man, including pre-clinical and clinical
    •  pharmacometabolomics for precision medicine
    •  metabolic profiling and fingerprinting
    •  metabolite target analysis
    •  metabolomic applications within animals, plants and microbes
    •  transcriptomics and proteomics in systems biology

    Metabolomics is an indispensable platform for researchers using new post-genomics approaches, to discover networks and interactions between metabolites, pharmaceuticals, SNPs, proteins and more. Its articles go beyond the genome and metabolome, by including original clinical study material together with big data from new emerging technologies.

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for Authors

    Instructions for Authors


  • Compliance with Ethical Requirements
  • Author Academy: Training for Authors
  • Copyright Information

    Copyright Information


    Copyright Information

    For Authors

    Submission of a manuscript implies: that the work described has not been published before (except in form of an abstract or as part of a published lecture, review or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as – tacitly or explicitly – by the responsible authorities at the institution where the work was carried out.

    Author warrants (i) that he/she is the sole owner or has been authorized by any additional copyright owner to assign the right, (ii) that the article does not infringe any third party rights and no license from or payments to a third party is required to publish the article and (iii) that the article has not been previously published or licensed. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright to Springer (respective to owner if other than Springer) becomes effective if and when a Copyright Transfer Statement is signed or transferred electronically by the corresponding author. After submission of the Copyright Transfer Statement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by Springer.

    The copyright to this article, including any graphic elements therein (e.g. illustrations, charts, moving images), is assigned for good and valuable consideration to Springer effective if and when the article is accepted for publication and to the extent assignable if assignability is restricted for by applicable law or regulations (e.g. for U.S. government or crown employees).

    The copyright assignment includes without limitation the exclusive, assignable and sublicensable right, unlimited in time and territory, to reproduce, publish, distribute, transmit, make available and store the article, including abstracts thereof, in all forms of media of expression now known or developed in the future, including pre- and reprints, translations, photographic reproductions and microform. Springer may use the article in whole or in part in electronic form, such as use in databases or data networks for display, print or download to stationary or portable devices. This includes interactive and multimedia use and the right to alter the article to the extent necessary for such use.

    Authors may self-archive the Author's accepted manuscript of their articles on their own websites. Authors may also deposit this version of the article in any repository, provided it is only made publicly available 12 months after official publication or later. He/she may not use the publisher's version (the final article), which is posted on SpringerLink and other Springer websites, for the purpose of self-archiving or deposit. Furthermore, the Author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com".

    Prior versions of the article published on non-commercial pre-print servers like arXiv.org can remain on these servers and/or can be updated with Author's accepted version. The final published version (in pdf or html/xml format) cannot be used for this purpose. Acknowledgement needs to be given to the final publication and a link must be inserted to the published article on Springer's website, accompanied by the text "The final publication is available at link.springer.com". Author retains the right to use his/her article for his/her further scientific career by including the final published journal article in other publications such as dissertations and postdoctoral qualifications provided acknowledgement is given to the original source of publication.

    Author is requested to use the appropriate DOI for the article. Articles disseminated via link.springer.com are indexed, abstracted and referenced by many abstracting and information services, bibliographic networks, subscription agencies, library networks, and consortia.

    For Readers

    While the advice and information in this journal is believed to be true and accurate at the date of its publication, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may have been made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

    All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from the publisher (respective the copyright owner if other than Springer). The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

    Springer has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Springer content. For permission to reuse our content please locate the material that you wish to use on link.springer.com or on springerimages.com and click on the permissions link or go to copyright.com, then enter the title of the publication that you wish to use. For assistance in placing a permission request, Copyright Clearance Center can be connected directly via phone: +1-855-239-3415, fax: +1-978-646-8600, or e-mail: info@copyright.com.

    © Springer Science+Business Media New York

Alerts for this journal


Get the table of contents of every new issue published in Metabolomics.

Additional information